Starr Kevin P Insider Trades

Insider Trading History

Track insider trading activity for Starr Kevin P. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Sage Therapeutics
Sage Therapeutics SAGE
Director
Holding Value $86.8k 10,000 shares
Last Trade
Jun 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$561k 10,000 shares
$56.10
$8.68
Sage Therapeutics
Sage Therapeutics SAGE
Director
Holding Value $86.3k 9,947 shares
Last Trade
Jun 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$312k 9,947 shares
$31.36
$8.68
Sage Therapeutics
Sage Therapeutics SAGE
Director
Holding Value $2.78M 320,659 shares
Last Trade
Jun 16, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1M 17,842 shares
$56.05
$8.68
Sage Therapeutics
Sage Therapeutics SAGE
Director
Holding Value $86.8k 10,000 shares
Last Trade
Jun 10, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$761k 10,000 shares
$76.09
$8.68
Sage Therapeutics
Sage Therapeutics SAGE
Director
Holding Value $86.8k 10,000 shares
Last Trade
Jun 09, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$365k 10,000 shares
$36.47
$8.68
Sage Therapeutics
Sage Therapeutics SAGE
Director
Holding Value $86.8k 10,000 shares
Last Trade
Jun 05, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.77M 10,000 shares
$177.41
$8.68
Sage Therapeutics
Sage Therapeutics SAGE
10% owner
Holding Value $86.8k 10,000 shares
Last Trade
Jun 06, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.54M 10,000 shares
$154.06
$8.68
Sage Therapeutics
Sage Therapeutics SAGE
Director
Holding Value $2.63M 302,817 shares
Last Trade
Apr 18, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.04M 24,000 shares
$168.28
$8.68
Sage Therapeutics
Sage Therapeutics SAGE
Director
Holding Value $2.84M 326,817 shares
Last Trade
Apr 17, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.92M 35,000 shares
$169.25
$8.68
Sage Therapeutics
Sage Therapeutics SAGE
Director
Holding Value $324k 37,362 shares
Last Trade
Feb 16, 2018 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$82.9M 510,554 shares
$162.37
$8.68
Sage Therapeutics
Sage Therapeutics SAGE
Director
Holding Value $4.76M 547,916 shares
Last Trade
Sep 27, 2017 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$34.4M 545,000 shares
$63.05
$8.68
Sage Therapeutics
Sage Therapeutics SAGE
Director
Holding Value $9.49M 1,092,916 shares
Last Trade
Jul 18, 2017 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$65.4M 800,000 shares
$81.69
$8.68
Sage Therapeutics
Sage Therapeutics SAGE
10% owner
Holding Value $122k 14,000 shares
Last Trade
Jun 07, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.02M 14,000 shares
$72.74
$8.68
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $3.42M 11,250 shares
Last Trade
Jun 02, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$810k 11,250 shares
$71.99
$303.64
CytomX Therapeutics
CytomX Therapeutics CTMX
10% owner
Holding Value $99.9k 31,419 shares
Last Trade
Apr 12, 2017 Sale (Open Market)Shares sold on the open market or in a private sale.
$464k 28,357 shares
$16.36
$3.18
Sage Therapeutics
Sage Therapeutics SAGE
Director
Holding Value $16.4M 1,892,916 shares
Last Trade
Jan 23, 2017 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$52.4M 1,000,000 shares
$52.35
$8.68
Blueprint Medicines
Blueprint Medicines BPMC
10% owner
Holding Value $0 0 shares
Last Trade
Dec 19, 2016 Sale (Open Market)Shares sold on the open market or in a private sale.
$3M 106,489 shares
$28.19
$129.46
Global Blood Therapeutics
Global Blood Therapeutics GBT
10% owner
Holding Value $5.65M 82,544 shares
Last Trade
Dec 16, 2016 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.74M 108,955 shares
$16.00
$68.49
Editas Medicine
Editas Medicine EDIT
10% owner
Holding Value $0 0 shares
Last Trade
Sep 06, 2016 Sale (Open Market)Shares sold on the open market or in a private sale.
$93.7k 5,890 shares
$15.90
$2.99
Sage Therapeutics
Sage Therapeutics SAGE
10% owner
Holding Value $25.1M 2,892,916 shares
Last Trade
Aug 19, 2016 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$36.5M 1,000,000 shares
$36.45
$8.68

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up